Pharmaceutical News and Articles

Comprehensive and up-to-date drug news for both consumers and healthcare professionals.

Makers Drag Feet Reporting Medical Device Side Effects: Study

and you might not find out in a timely manner. That s because medical device manufacturers frequently fail to promptly report side effects caused by their wares

Babies With Heart Defects Also Prone To Cancer

Newborns with a heart defect may have two strikes against their future health, rather than one. Babies with heart birth defects appear to have a higher risk of

Chest CT Scans Can Help Diagnose Pneumonia

Low-dose CT chest scans could help detect pneumonia in at-risk patients while exposing them to small amounts of radiation, a new study says. Ultra-low-dose scan

Glucose Monitors Improve Traffic Safety For Diabetic Drivers

the devices also can help them be safer drivers. Diabetics who use glucose monitors have fewer incidents involving low blood sugar, researchers reported in Diab

Prompt CPR Saves Lives, Regardless Of Who Performs It

when performed promptly, it will increase a person s odds of survival, a new study says. The speed of CPR initiation is crucial to survival and better outcomes

FDA Issues Warning Against Recreational Inhalation of Nitrous Oxide

The U.S. Food and Drug Administration is cautioning consumers against the recreational use of any flavor of nitrous oxide (also known as laughing gas) from cani

Risk of Developing Cancer Up for Children With Congenital Heart Disease

Children with congenital heart disease (CHD) have increased risk of developing cancer, according to a research letter published in the March 18 issue of Circula

Surgery in Kids with Mild Sleep-Disordered Breathing Tied to Fewer Doctor Visits, Meds

Surgical removal of enlarged tonsils and adenoids in children with mild sleep-disordered breathing (SDB) appears to significantly reduce the frequency of medica

NIH-Funded Study Identifies Potential New Stroke Treatment

In a preclinical study, rodents treated with uric acid showed improved long-term outcomes after acute ischemic stroke. The findings suggest that the treatment m

Eneboparatide Met Primary Endpoint of Normalising Serum Calcium in Adults with Hypoparathyroidism at 24 weeks in CALYPSO Phase III Trial

High-level results from the CALYPSO Phase III trial showed that eneboparatide (AZP-3601), an investigational parathyroid hormone (PTH) receptor 1 agonist, met i

Popular Keywords